These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8840151)

  • 1. Protective effect of recombinant interferon (IFN)-alpha/beta on MHV-2cc-induced chronic hepatitis in athymic nude mice.
    Uetsuka K; Nakayama H; Goto N
    Exp Anim; 1996 Jul; 45(3):293-7. PubMed ID: 8840151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of a novel quinone derivative, E3330, on mouse hepatitis virus (MHV)-induced chronic hepatitis in athymic nude mice.
    Uetsuka K; Suzuki M; Kai C; Goto N
    Exp Anim; 1997 Jul; 46(3):219-23. PubMed ID: 9250483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus.
    Fuchizaki U; Kaneko S; Nakamoto Y; Sugiyama Y; Imagawa K; Kikuchi M; Kobayashi K
    J Med Virol; 2003 Feb; 69(2):188-94. PubMed ID: 12683406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels.
    Roth-Cross JK; Martínez-Sobrido L; Scott EP; García-Sastre A; Weiss SR
    J Virol; 2007 Jul; 81(13):7189-99. PubMed ID: 17459917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitogenicity of three plaque purified variants of hepatotropic mouse hepatitis virus, MHV-2 in athymic nude mice.
    Uetsuka K; Nakayama H; Goto N
    Exp Anim; 1996 Apr; 45(2):183-7. PubMed ID: 8726145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
    Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
    J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection.
    Minagawa H; Takenaka A; Mohri S; Mori R
    Antiviral Res; 1987 Sep; 8(2):85-95. PubMed ID: 2830846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis.
    Muse M; Kane JA; Carr DJ; Farber JM; Lane TE
    Virology; 2008 Dec; 382(2):132-44. PubMed ID: 18973912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.
    Compton SR; Ball-Goodrich LJ; Zeiss CJ; Johnson LK; Johnson EA; Macy JD
    Comp Med; 2003 Apr; 53(2):197-206. PubMed ID: 12784855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between BALB/c and C57BL/6 mice in mouse hepatitis virus replication in primary hepatocyte culture.
    Kyuwa S; Kawamura S; Tagawa Y; Iwakura Y; Urano T; Yoshikawa Y
    Exp Anim; 2003 Jan; 52(1):81-4. PubMed ID: 12638242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.
    Navas S; Seo SH; Chua MM; Das Sarma J; Lavi E; Hingley ST; Weiss SR
    J Virol; 2001 Mar; 75(5):2452-7. PubMed ID: 11160748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and duration of mouse hepatitis virus in naturally infected immunocompetent ICR (CD-1) and immunodeficient athymic nude-nu mouse strains used for ovarian transplantation and in vitro fertilization.
    Scavizzi F; Raspa M
    Lab Anim; 2004 Apr; 38(2):189-99. PubMed ID: 15070459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective role of cytotoxic T cells and interferon against coronavirus invasion of the brain.
    Lavi E; Wang Q
    Adv Exp Med Biol; 1995; 380():145-9. PubMed ID: 8830471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease.
    Barthold SW; Beck DS; Smith AL
    Lab Anim Sci; 1993 Aug; 43(4):276-84. PubMed ID: 8231082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages.
    Butchi NB; Hinton DR; Stohlman SA; Kapil P; Fensterl V; Sen GC; Bergmann CC
    J Virol; 2014 Jan; 88(2):1051-64. PubMed ID: 24198415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection.
    Cervantes-Barragán L; Kalinke U; Züst R; König M; Reizis B; López-Macías C; Thiel V; Ludewig B
    J Immunol; 2009 Jan; 182(2):1099-106. PubMed ID: 19124753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice.
    Smith AL; Barthold SW; Beck DS
    Antiviral Res; 1987 Dec; 8(5-6):239-45. PubMed ID: 2837142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ.
    Wu D; Yan WM; Wang HW; Huang D; Luo XP; Ning Q
    Curr Med Sci; 2018 Aug; 38(4):648-655. PubMed ID: 30128874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of murine recombinant interferon-beta administered by intravenous, intramuscular or subcutaneous route on mouse hepatitis virus infection.
    Matsuyama S; Henmi S; Ichihara N; Sone S; Kikuchi T; Ariga T; Taguchi F
    Antiviral Res; 2000 Aug; 47(2):131-7. PubMed ID: 10996401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
    Kawamoto S; Oritani K; Asada H; Takahashi I; Ishikawa J; Yoshida H; Yamada M; Ishida N; Ujiie H; Masaie H; Tomiyama Y; Matsuzawa Y
    J Virol; 2003 Sep; 77(17):9622-31. PubMed ID: 12915574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.